Regional News

Ascentage Pharma to Present at the 41st Annual J.P. Morgan Healthcare Conference

SUZHOU, China and ROCKVILLE, Md., Jan. 4, 2023 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that its Chairman and CEO, Dr.Dajun Yang, has accep...

2023-01-05 09:00 3083

Duality Biologics Announces License Agreement of its Next-generation ADC platform with Adcendo

* Duality to grant license of DITAC (Duality Immune Toxin Antibody Conjugates) platform to Adcendo for its lead uPARAP ADC program * Duality to receive upfront payment, development, regulatory and commercial milestones, and tiered royalties * Collaboration based on synergies between Adcendo ...

2023-01-05 09:00 1872

Sphera Marks a Decade as a Market Leader in EHS Software in Independent Analyst Report

The 2023 Green Quadrant EHS Software report sees Sphera receiving top scores for ESG and sustainability management, as well as air emissions management CHICAGO, Jan. 5, 2023 /PRNewswire/ -- Sphera, a leading global provider of Environmental, Social and Governance (ESG) performance and risk manage...

2023-01-05 09:00 2471

Strong performer for RPA, Cyclone Robotics, is the Customer Choice for APAC region

SINGAPORE, Jan. 5, 2023 /PRNewswire/ -- Leading provider of robotic software and solutions, Cyclone Robotics has been recognised by Gartner's Magic Quadrant for the second consecutive year, for its ability to execute, as well as completeness of its vision. This honour sees Cyclone Robotics being ...

2023-01-05 09:00 5083

C2A Security Partners with Valeo to Enhance Cybersecurity for the Software Defined Vehicle

Valeo to utilize C2A's Cybersecurity DevOps & Automation Platform to scale its cybersecurity software lifecycle management and provide greater security for its customers and modern vehicles JERUSALEM, Jan. 5, 2023 /PRNewswire/ -- Valeo, a leading automotive supplier, and partner to automakers wo...

2023-01-05 09:00 3231

WuXi Biologics and GSK Enter into License Agreement on Multiple Novel Bi- & Multi-specific T Cell Engagers

* WuXi Biologics will provide an exclusive license to GSK for one preclinical bi-specific T cell engaging (TCE) antibody and the option of three additional bi-/multi-specific TCE antibodies developed using WuXi Biologics' proprietary technology platforms * WuXi Biologics will receive an upfro...

2023-01-05 08:30 5527

CardsPal named the official Ticketing Partner for Seedly Personal Finance Festival 2023, Singapore's biggest personal finance festival

SINGAPORE, Jan. 5, 2023 /PRNewswire/ -- CardsPal has secured another win by being appointed as the official ticketing partner for Seedly Personal Finance Festival 2023, leveraging on its e-ticketing feature launched inSep 2022. Following the success of Glowhard, Singapore's first ever Hard Dance ...

2023-01-05 08:30 3054

DiscGenics to Present at 41st Annual J.P. Morgan Healthcare Conference

SALT LAKE CITY, Jan. 5, 2023 /PRNewswire/ -- DiscGenics, Inc., a privately held, clinical stage biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine, today announced that it w...

2023-01-05 08:00 2600

Innovent Announces NMPA's Breakthrough Therapy Designation for IBI351 (KRAS G12C Inhibitor) as Monotherapy for Previous Treated Advanced Non-small Cell Lung Cancer

ROCKVILLE, Md. and SUZHOU, China, Jan. 5, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology and...

2023-01-05 08:00 5246

INUITIVE AND VISIDON INTRODUCE A NEW, INDUSTRY-CHANGING LOW LIGHT ENHANCEMENT TECHNOLOGY FOR ROBOTIC APPLICATIONS AND MORE

The solution's fast, neural networks-based low light enhancement capability functions in real time, enabling precision in robotic applications in highly challenging light conditions RA'ANANA, Israel, Jan. 5, 2023 /PRNewswire/ -- Inuitive , a leading vision-on-chip...

2023-01-05 08:00 3368

A Cross-Generational Upgrade for Hisense, ULED X Technology Debuts at CES 2023

LAS VEGAS, Jan. 5, 2023 /PRNewswire/ -- On January 4th, Hisense unveiled ULED X at Hisense CES 2023 Press Conference, a milestone in LCD TV technology for Hisense. ULED X represents a significant advancement in LCD television technology that offers the best ever picture quality in every frame and...

2023-01-05 07:57 4212

Hisense CES 2023: Expanding Global Footprint and Paving the Way for Ongoing Growth

LAS VEGAS, Jan. 5, 2023 /PRNewswire/ -- On January 4th, David Gold, President of HisenseUSA, delivered a speech at Hisense CES 2023 Press Conference, sharing Hisense's international growth and successes in terms of its global layout, technology innovations, B2B business, smart development, and it...

2023-01-05 07:19 4744

Cognos Therapeutics, Inc. to Become Publicly Listed on Nasdaq via Business Combination with Nocturne Acquisition Corporation

* Cognos Therapeutics is a medical technology company focused on developing unique, radically advanced devices for the treatment of neurological diseases including brain and spinal cancers, and degenerative neurological conditions (such as Alzheimer's and Parkinson's disease), epilepsy, and str...

2023-01-05 07:10 5119

HD Hyundai Announces a New "Ocean Transformation" Vision

Capitalizing the Ocean's Potential to Realize a Sustainable Future * Kisun Chung, CEO of HD Hyundai announces core vision to drive "Ocean Transformation" * HD Hyundai aims to pioneer the ocean's infinite potential, expand human territory and lead sustainable growth * Top executives of partn...

2023-01-05 07:00 2454

MultiMetaVerse Inc. and Model Performance Acquisition Corp. Complete Business Combination

- MMV Ordinary Shares and Warrants to Trade on Nasdaq under Ticker Symbols "MMV" and "MMVWW", respectively NEW YORK, Jan. 4, 2023 /PRNewswire/ -- MultiMetaVerse Inc., an animation and entertainment company devoted to establishing an open community for its global users and to providing high-quali...

2023-01-05 05:55 4221

TCL Announces a Series of New Connected Products that Improve Display Experiences at CES 2023

LAS VEGAS, Jan. 4, 2023 /PRNewswire/ -- TCL , a pioneer in display technology and affordable, smart connected experiences, announces a suite of new products at CES 2023. The line-up includes a range of smart products, including the TCL 40 Series smartphone range...

2023-01-05 05:00 3191

TCL Unveils Groundbreaking Augmented Reality Glasses at CES 2023

TCL RayNeo X2 delivers a truly smart wearable experience which unlocks a deeper connection between users, their devices, and the real world LAS VEGAS, Jan. 4, 2023 /PRNewswire/ -- TCL , a pioneer in display technology and affordable, premium smart experiences, ...

2023-01-05 05:00 3562

TCL Expands Pioneering NXTPAPER Technology into New Products

LAS VEGAS, Jan. 4, 2023 /PRNewswire/ -- TCL , a leader in display technology and affordable, premium smart experiences, announces new devices with upgraded NXTPAPER technology. The pioneering display technology expands into new product categories, including a ne...

2023-01-05 05:00 2779

TCL Announces Innovative Advancements in Technology and More at CES 2023

HONG KONG, Jan. 5, 2023 /PRNewswire/ -- TCL, a leading consumer electronics brand and one of the dominant players in the global TV industry, held its CES 2023 press conference today ahead of the annual technology exhibition start. The company revealed newsworthy updates on the latest corporate in...

2023-01-05 05:00 3979

SK to showcase cutting-edge 'Net-Zero' technologies at CES 2023

* SK to display over 40 eco-friendly technologies and products ranging from state-of-the-art batteries for electric vehicles to Urban Air Mobility solutions and sustainable foods * Eight SK companies and 10 global partner companies to demonstrate technological capabilities for cutting carbon ...

2023-01-05 04:58 3275

Week's Top Stories